We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRMD icon
3176
KORU Medical Systems
KRMD
$159M
– –
-2,887
Closed -$6.81K
KVHI icon
3177
KVH Industries
KVHI
$151M
– –
-1,549
Closed -$7.9K
KZR
3178
DELISTED
Kezar Life Sciences
KZR
– –
-413
Closed -$3.72K
LEG icon
3179
Leggett & Platt
LEG
$1.3B
– –
-29,872
Closed -$572K
LPSN icon
3180
LivePerson
LPSN
$33.6M
– –
-481
Closed -$7.2K
MAXN
3181
DELISTED
Maxeon Solar Technologies
MAXN
– –
-25
Closed -$8.29K
MCRB icon
3182
Seres Therapeutics
MCRB
$46.6M
– –
-402
Closed -$6.22K
MNSB icon
3183
MainStreet Bancshares
MNSB
$174M
– –
-575
Closed -$10.4K
MPLX icon
3184
MPLX
MPLX
$60.1B
– –
-13,420
Closed -$558K
MSTR icon
3185
Strategy Inc
MSTR
$37.8B
– –
-14,820
Closed -$2.53M
MURA
3186
DELISTED
Mural Oncology
MURA
– –
-1,648
Closed -$8.06K
MVST icon
3187
Microvast
MVST
$288M
– –
-22,256
Closed -$18.6K
NB
3188
NioCorp Developments
NB
$780M
– –
-161
Closed -$438
NDLS icon
3189
Noodles & Co
NDLS
$93M
– –
-399
Closed -$6.09K
NVCT icon
3190
Nuvectis Pharma
NVCT
$632M
– –
-566
Closed -$4.64K
OM icon
3191
Outset Medical
OM
$90.6M
– –
-327
Closed -$10.9K
OPI
3192
DELISTED
Office Properties Income Trust
OPI
– –
-3,755
Closed -$7.66K
OPTN
3193
DELISTED
OptiNose
OPTN
– –
-401
Closed -$8.79K
ORGN
3194
DELISTED
Origin Materials
ORGN
– –
-349
Closed -$5.33K
PDSB icon
3195
PDS Biotechnology
PDSB
$14.4M
– –
-2,309
Closed -$9.14K
PENN icon
3196
PENN Entertainment
PENN
$2.57B
– –
-32,855
Closed -$598K
PETS icon
3197
PetMed Express
PETS
$42.3M
– –
-1,778
Closed -$8.52K
PIII icon
3198
P3 Health Partners
PIII
$41.1M
– –
-38
Closed -$1.97K
PLCE icon
3199
Children's Place
PLCE
$56.3M
– –
-1,078
Closed -$12.4K
PLX icon
3200
Protalix BioTherapeutics
PLX
$196M
– –
-4,638
Closed -$5.84K
126 127
128
129 130

Similar funds

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
PCM
Prana Capital Management Greenwich, Connecticut $3.29B AUM 2.24% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
SYBT
Stock Yards Bank & Trust Louisville, Kentucky $3.21B AUM 22.76% 1-Year Est. Return
SM
SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
YCM
Yaupon Capital Management New York $3.2B AUM 46.52% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.